Erythropoietin depletes iron stores: antioxidant neuroprotection for ischemic stroke?

Stroke. 2006 Oct;37(10):2453. doi: 10.1161/01.STR.0000239787.92203.16. Epub 2006 Aug 17.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Antioxidants / therapeutic use*
  • Brain Chemistry / drug effects
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / metabolism
  • Catalysis
  • Chelating Agents / therapeutic use
  • Erythropoietin / pharmacology
  • Erythropoietin / therapeutic use*
  • Ferritins / blood
  • Ferrous Compounds / administration & dosage
  • Hematocrit
  • Hemoglobins / analysis
  • Humans
  • Iron / metabolism*
  • Male
  • Neuroprotective Agents / therapeutic use*
  • Oxidation-Reduction
  • Oxidative Stress
  • Recombinant Proteins
  • Transferrin / analysis

Substances

  • Antioxidants
  • Chelating Agents
  • Ferrous Compounds
  • Hemoglobins
  • Neuroprotective Agents
  • Recombinant Proteins
  • Transferrin
  • Erythropoietin
  • ferrous sulfate
  • Ferritins
  • Iron